AMENDMENT TO LICENSE AGREEMENTLicense Agreement • January 6th, 2016 • Biolargo, Inc. • Chemicals & allied products
THIS AMENDMENT TO LICENSE AGREEMENT (“Amendment”) is made and entered into as of this December 30, 2015 by and between BIOLARGO, INC., a Delaware corporation, and its wholly owned subsidiary BioLargo Life Technologies, Inc., a California corporation (collectively, “Licensor”), and CLYRA MEDICAL TECHNOLOGIES, INC., a California corporation (“Licensee”), with respect to the following:
LICENSE AGREEMENTLicense Agreement • January 6th, 2016 • Biolargo, Inc. • Chemicals & allied products • California
This License Agreement (the “Agreement”) is made this 17th day of December, 2012, by and between BioLargo, Inc., a Delaware corporation and its wholly owned subsidiary BioLargo Life Technologies, Inc., a California corporation, having a principal place of business at 16150 Heron Avenue, La Mirada, California (collectively referred to as “BioLargo”), and Clyra Medical Technologies, Inc., a California corporation having a principal place of business at 16150 Heron Avenue, La Mirada, California (“Clyra”). Each of BioLargo and Clyra is a “Party”, and are collectively referred to herein as the “Parties”.
CONSULTING AGREEMENTConsulting Agreement • January 6th, 2016 • Biolargo, Inc. • Chemicals & allied products • California
THIS CONSULTING AGREEMENT (“Agreement”) is entered into as of the 30th day of December, 2015 (the “Effective Date”), by and between Beach House Consulting, LLC, a Minnesota limited liability company (“Consultant”) and Clyra Medical Technologies, Inc., a California corporation (“Client”). Consultant and Client are individually referred to herein as a “Party” and collectively as the “Parties.”
biolargo, inc. INVESTORS’ RIGHTS AGREEMENTInvestors' Rights Agreement • January 6th, 2016 • Biolargo, Inc. • Chemicals & allied products • California
THIS BIOLARGO, INC. INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 30th day of December, 2015, by and among BioLargo, Inc., a Delaware corporation (the “Company”), Jack B. Strommen (“Strommen”), and Sanatio Capital, LLC, a Minnesota limited liability company (“Sanatio”) (each of Strommen and Sanatio may be referred to in this Agreement as an “Investor”).
